PEAK6 Investments’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$384K Sell
20,750
-39,910
-66% -$801K ﹤0.01% 2467
2024
Q2
$1.23M Sell
60,660
-345
-0.6% -$6.11K ﹤0.01% 1679
2024
Q1
$1.04M Buy
61,005
+31,459
+106% +$495K ﹤0.01% 1905
2023
Q4
$522K Buy
+29,546
New +$595K ﹤0.01% 2578
2022
Q2
Sell
-37,461
Closed -$995K 4140
2022
Q1
$1.19M Buy
37,461
+33,315
+804% +$934K ﹤0.01% 2339
2021
Q4
$92K Sell
4,146
-3,857
-48% -$101K ﹤0.01% 4395
2021
Q3
$222K Sell
8,003
-4,132
-34% -$126K ﹤0.01% 3910
2021
Q2
$473K Buy
12,135
+8,087
+200% +$290K ﹤0.01% 3292
2021
Q1
$117K Buy
+4,048
New +$138K ﹤0.01% 4211
2020
Q3
Sell
-2,336
Closed -$49K 4421
2020
Q2
$47K Sell
2,336
-2,223
-49% -$39.8K ﹤0.01% 4027
2020
Q1
$47K Sell
4,559
-1,058
-19% -$29.6K ﹤0.01% 3611
2019
Q4
$212K Sell
5,617
-100,113
-95% -$4.5M ﹤0.01% 2504
2019
Q3
$4.87M Buy
105,730
+73,160
+225% +$3.4M 0.03% 689
2019
Q2
$1.7M Buy
32,570
+12,624
+63% +$740K 0.01% 1416
2019
Q1
$1.38M Buy
19,946
+9,392
+89% +$630K 0.01% 1581
2018
Q4
$630K Sell
10,554
-5,866
-36% -$506K ﹤0.01% 2166
2018
Q3
$1.9M Buy
+16,420
New +$1.85M 0.01% 1468

Other funds holding CLB

PEAK6 Investments's CLB Position: Q3 2024 in Review

PEAK6 Investments reduced its Core Laboratories (CLB) stake by 66% in Q3 2024, selling an estimated $801K and leaving 20,750 shares worth $384K. The position accounts for ﹤0.01% of the portfolio, ranked #2467.

PEAK6 Investments first reported a position in CLB in Q3 2018 and has held it in 17 quarters since. The position peaked at $4.87M in Q3 2019. 191 funds tracked by Wall St. Rank hold CLB as of Q3 2024.

  • PEAK6 Investments held 20,750 shares of Core Laboratories worth $384K as of Q3 2024.
  • PEAK6 Investments sold 39,910 Core Laboratories shares in Q3 2024, an estimated $801K.
  • Core Laboratories made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2467 holding.
  • PEAK6 Investments first reported a position in Core Laboratories in Q3 2018 and has held it in 17 quarters since.
  • PEAK6 Investments's Core Laboratories position peaked at $4.87M in Q3 2019.
  • 191 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.